INTRODUCTION: Computed tomography perfusion (CTP) and magnetic resonance perfusion (MRP) are expected to be usable for ancillary tests of brain death by detection of complete absence of cerebral perfusion; however, the detection limit of hypoperfusion has not been determined. Hence, we examined whether commercial software can visualize very low cerebral blood flow (CBF) and cerebral blood volume (CBV) by creating and using digital phantoms. METHODS: Digital phantoms simulating 0-4% of normal CBF (60 mL/100 g/min) and CBV (4 mL/100 g/min) were analyzed by ten software packages of CT and MRI manufacturers. Region-of-interest measurements were performed to determine whether there was a significant difference between areas of 0% and areas of 1-4% of normal flow. RESULTS: The CTP software detected hypoperfusion down to 2-3% in CBF and 2% in CBV, while the MRP software detected that of 1-3% in CBF and 1-4% in CBV, although the lower limits varied among software packages. CONCLUSION: CTP and MRP can detect the difference between profound hypoperfusion of <5% from that of 0% in digital phantoms, suggesting their potential efficacy for assessing brain death.
INTRODUCTION: Computed tomography perfusion (CTP) and magnetic resonance perfusion (MRP) are expected to be usable for ancillary tests of brain death by detection of complete absence of cerebral perfusion; however, the detection limit of hypoperfusion has not been determined. Hence, we examined whether commercial software can visualize very low cerebral blood flow (CBF) and cerebral blood volume (CBV) by creating and using digital phantoms. METHODS: Digital phantoms simulating 0-4% of normal CBF (60 mL/100 g/min) and CBV (4 mL/100 g/min) were analyzed by ten software packages of CT and MRI manufacturers. Region-of-interest measurements were performed to determine whether there was a significant difference between areas of 0% and areas of 1-4% of normal flow. RESULTS: The CTP software detected hypoperfusion down to 2-3% in CBF and 2% in CBV, while the MRP software detected that of 1-3% in CBF and 1-4% in CBV, although the lower limits varied among software packages. CONCLUSION:CTP and MRP can detect the difference between profound hypoperfusion of <5% from that of 0% in digital phantoms, suggesting their potential efficacy for assessing brain death.
Authors: R Bohatyrewicz; M Sawicki; A Walecka; J Walecki; O Rowinski; A Bohatyrewicz; A Kanski; Z Czajkowski; A Krzysztalowski; J Solek-Pastuszka; M Zukowski; E Marzec-Lewenstein; M Wojtaszek Journal: Transplant Proc Date: 2010-12 Impact factor: 1.066
Authors: Dolores Escudero; Jesús Otero; Lara Marqués; Diego Parra; José Antonio Gonzalo; Guillermo M Albaiceta; Luis Cofiño; Armando Blanco; Pedro Vega; Eduardo Murias; Angela Meilan; Ricardo López Roger; Francisco Taboada Journal: Neurocrit Care Date: 2009-06-30 Impact factor: 3.210
Authors: Irene Klærke Mikkelsen; P Simon Jones; Lars Riisgaard Ribe; Josef Alawneh; Josep Puig; Susanne Lise Bekke; Anna Tietze; Jonathan H Gillard; Elisabeth A Warburton; Salva Pedraza; Jean-Claude Baron; Leif Østergaard; Kim Mouridsen Journal: Eur Radiol Date: 2015-04-17 Impact factor: 5.315
Authors: M Sawicki; R Bohatyrewicz; K Safranow; A Walecka; J Walecki; O Rowinski; J Solek-Pastuszka; Z Czajkowski; E Marzec-Lewenstein; K Motyl; W Przybyl; A Czarnecka Journal: Neuroradiology Date: 2013-06-02 Impact factor: 2.804
Authors: Marcin Sawicki; Joanna Sołek-Pastuszka; Katarzyna Chamier-Ciemińska; Anna Walecka; Romuald Bohatyrewicz Journal: Med Sci Monit Date: 2018-05-04